Kailera Therapeutics, Inc. Common Stock (KLRA) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for KLRA. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 94 institutions reported holding KLRA, with 116.0 million shares worth $2.6 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Bain Capital Investors | 26,255,581 | $578M | NEW |
| Bain Capital Life Sciences Investors | 22,583,268 | $498M | NEW |
| Rtw Investments | 10,776,820 | $237M | NEW |
| CPP Investments | 7,304,688 | $161M | NEW |
| Atlas Venture Life Science Advisors | 5,171,282 | $114M | NEW |
Full institutional holdings, insider history, and congressional trades for Kailera Therapeutics, Inc. Common Stock on SentiSense.